0
Assembly Biosciences Inc Banner Image

Assembly Biosciences Inc

  • Ticker ASMB
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
Assembly Biosciences Inc Logo Image
  • 51-200 Employees
  • Based in South San Francisco, California
Assembly Biosciences, Inc., a biopharmaceutical company, develops oral therapies for intractable infectious diseases in the United States. The company focuses on the hepatitis B virus (HBV) and C. difficile-associated infections (CDAD). It is involved in developing core protein allosteric modulators that modulate the HBV core protein, a polyfunctional viral protein, at various complementaryMore points in the viral lifecycle; and microbiome program, a treatment for CDAD, for targeted delivery of complex agents to select regions of the gastrointestinal tract.
REPORT RATINGS
4.8 / 5.0 (216)

Assembly Biosciences Inc reports have an aggregate usefulness score of 4.8 based on 216 reviews.

Assembly Biosciences Inc

Most Recent Annual Report

Assembly Biosciences Inc
MOST RECENT 2022 Annual Report and Form 10K

Assembly Biosciences Inc does not currently have any hardcopy reports on AnnualReports.com. Click the button below to request a report when hardcopies become available.

Request Information

Older/Archived Annual Reports

Assembly Biosciences Inc Logo Image

Rate This Report

Your vote helps our reports be more useful
Rating Saved!

Thank you for your feedback!